Oliver Hantschel. Allosteric BCR-ABL inhibitors in Philadelphia chromosome-positive acute lymphoblastic leukemia: novel opportunities for drug combinations to overcome resistance. haematol [Internet]. 2012Jan.31 [cited 2024Nov.22];97(2):157-9. Available from: https://haematologica.org/article/view/6200